Article Text
Letter
Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension
Statistics from Altmetric.com
Footnotes
Competing interests: None.
Funding: This study was supported by a grant from Genentech.
Ethics approval: Ethics approval was provided by the IRB of The New York Eye Cancer Center.
Patient consent: Obtained.